🔎 Trials Near Me

Pradžia › Širdies nepakankamumas › West Virginia

Širdies nepakankamumas klinikiniai tyrimai West Virginia

8 tyrimai dėl Širdies nepakankamumas ieško dalyvių vietose West Virginia.

Miestai West Virginia

Oficialus tyrimo tekstas (anglų kalba)

ELEVATE-HFpEF Clinical Study

  • Charleston Area Medical Center (CAMC) Memorial Hospital, Charleston
Renkami dalyviai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06678841

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  • Research Site, Kingwood
  • Research Site, Morgantown
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07761117

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  • Research Site, Kingwood
  • Research Site, Morgantown
Renkami dalyviai3 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT06677060

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • WVU Medicine, Morgantown
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT07567001

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • West Virginia University, Morgantown
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-29 · NCT05934487

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  • West Virginia Childrens Hospital, Morgantown
  • West Virginia Childrens Hospital, Morgantown
Renkami dalyviai3 fazė
Amžius nuo 6 iki 11 · Visoms lytims · Atnaujinta 2026-05-15 · NCT06597019

Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients

  • West Virginia School of Osteopathic Medicine, Lewisburg
Renkami dalyviai
Amžius nuo 18 iki 64 · Visoms lytims · Atnaujinta 2025-07-25 · NCT06049420

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.